{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:34:34Z","timestamp":1790678074525,"version":"4.1.0"},"reference-count":117,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2018,1,13]],"date-time":"2018-01-13T00:00:00Z","timestamp":1515801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JFB"],"abstract":"<jats:p>Bisphosphonates (BPs) are the most utilized drugs for the treatment of osteoporosis, and are usefully employed also for other pathologies characterized by abnormally high bone resorption, including bone metastases. Due to the great affinity of these drugs for calcium ions, calcium phosphates are ideal delivery systems for local administration of BPs to bone, which is aimed to avoid\/limit the undesirable side effects of their prolonged systemic use. Direct synthesis in aqueous medium and chemisorptions from solution are the two main routes proposed to synthesize BP functionalized calcium phosphates. The present review overviews the information acquired through the studies on the interaction between bisphosphonate molecules and calcium phosphates. Moreover, particular attention is addressed to some important recent achievements on the applications of BP functionalized calcium phosphates as biomaterials for bone substitution\/repair.<\/jats:p>","DOI":"10.3390\/jfb9010006","type":"journal-article","created":{"date-parts":[[2018,1,15]],"date-time":"2018-01-15T04:01:55Z","timestamp":1515988915000},"page":"6","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["Calcium Phosphates as Delivery Systems for Bisphosphonates"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2668-8627","authenticated-orcid":false,"given":"Adriana","family":"Bigi","sequence":"first","affiliation":[{"name":"Department of Chemistry \u201cG. Ciamician\u201d, University of Bologna, 40126 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3754-0273","authenticated-orcid":false,"given":"Elisa","family":"Boanini","sequence":"additional","affiliation":[{"name":"Department of Chemistry \u201cG. Ciamician\u201d, University of Bologna, 40126 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,1,13]]},"reference":[{"key":"ref_1","unstructured":"Aparicio, C., and Ginebra, M.P. (2015). Ion substitution in biological and synthetic apatites. Biomineralization and Biomaterials, Foundamentals and Applications, Woodhead Publishing (Imprint Elsevier)."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1016\/j.biomaterials.2007.06.023","article-title":"A tissue engineering approach to bone repair in large animal models and in clinical practice","volume":"28","author":"Cancedda","year":"2007","journal-title":"Biomaterials"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.actbio.2017.07.033","article-title":"In vitro degradation of calcium hosphates: Effect of multiscale porosity, textural properties and composition","volume":"60","author":"Espanol","year":"2017","journal-title":"Acta Biomater."},{"key":"ref_4","first-page":"e313","article-title":"Functionalized biomimetic calcium phosphates for bone tissue repair","volume":"15","author":"Bigi","year":"2017","journal-title":"J. Appl. Biomater. Funct. Mater."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bone.2011.04.022","article-title":"Bisphosphonates: The first 40 years","volume":"49","author":"Russell","year":"2011","journal-title":"Bone"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jconrel.2013.01.032","article-title":"Biomedical applications of bisphosphonates","volume":"167","author":"Giger","year":"2013","journal-title":"J. Control. Release"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.drudis.2014.04.004","article-title":"Therapeutic strategies for treating osteolytic bone metastases","volume":"19","author":"Verron","year":"2014","journal-title":"Drug Discov. Today"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1210\/jc.2005-0057","article-title":"Long-term safety of bisphosphonates","volume":"90","author":"Ott","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.drudis.2013.08.010","article-title":"Is bisphosphonate therapy compromised by the emergence of adverse bone disorders?","volume":"19","author":"Verron","year":"2014","journal-title":"Drug Discov. Today"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10717544.2013.870259","article-title":"Bisphosphonates: Therapeutics potential and recent advances in drug delivery","volume":"22","author":"Fazil","year":"2015","journal-title":"Drug Deliv."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00198-007-0540-8","article-title":"Mechanisms of action of bisphosphonates: Similarities and differences and their potential influence on clinical efficacy","volume":"19","author":"Russell","year":"2008","journal-title":"Osteoporos. Int."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"m543","DOI":"10.1107\/S0108270103025599","article-title":"Alendronate zwitterions bind to calcium cations arranged in columns","volume":"59","author":"Fernandez","year":"2003","journal-title":"Acta Cryst. Sect. C"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.biomaterials.2007.10.040","article-title":"Alendronate hydroxyapatite nanocomposites and their interaction with osteoclasts and osteoblast-like cells","volume":"29","author":"Boanini","year":"2008","journal-title":"Biomaterials"},{"key":"ref_14","first-page":"149","article-title":"Differences between bisphosphonates in binding affinities for hydroxyapatite","volume":"92","author":"Lawson","year":"2009","journal-title":"J. Biomed. Mater. Res. Part B"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.addr.2015.10.005","article-title":"Targeted delivery to bone and mineral deposits using bisphosphonate ligands","volume":"99","author":"Cole","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_16","first-page":"S259","article-title":"A computational model delineates differences in hydroxyapatite binding affinities of bisphosphonate","volume":"20","author":"Ebetino","year":"2005","journal-title":"J. Bone Miner. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bone.2010.11.008","article-title":"Biochemical and molecular mechanisms of action of bisphosphonates","volume":"49","author":"Rogers","year":"2011","journal-title":"Bone"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.canlet.2007.07.007","article-title":"Bisphosphonates in cancer therapy","volume":"257","author":"Stresing","year":"2007","journal-title":"Cancer Lett."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1039\/c2cc17635a","article-title":"Coercing bisphosphonates to kill cancer cells with nanoscale coordination polymers","volume":"48","author":"Liu","year":"2012","journal-title":"Chem. Commun."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.bone.2010.09.035","article-title":"Nitrogen-containing bisphosphonates can inhibit angiogenesis in vivo without the involvement of farnesyl pyrophosphate synthase","volume":"48","author":"Stresing","year":"2011","journal-title":"Bone"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.1016\/j.actbio.2014.07.012","article-title":"Vertebroplasty using bisphosphonate-loaded calcium phosphate cement in a standardized vertebral body bone defect in an osteoporotic sheep model","volume":"10","author":"Verron","year":"2014","journal-title":"Acta Biomater."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1749-6632.2010.05766.x","article-title":"The use of bisphosphonates in cancer treatment","volume":"1218","author":"Coleman","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1053\/j.seminoncol.2010.06.008","article-title":"Potential anticancer properties of bisphosphonates","volume":"37","author":"Gnant","year":"2010","journal-title":"Semin. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1172\/JCI114100","article-title":"Inhibition of osteoclast-like cell formation by bisphosphonates in long term cultures of human bone marrow","volume":"83","author":"Hughes","year":"1989","journal-title":"J. Clin. Investig."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1172\/JCI114459","article-title":"Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro","volume":"85","author":"Carano","year":"1990","journal-title":"J. Clin. Investig."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"34967","DOI":"10.1074\/jbc.274.49.34967","article-title":"Bisphosphonates act directly ion the osteoclast to induce caspase cleavage of MST 1 kinase during apoptosis. A link between inhibition of the mevalonate pathway and regulation of an apoptosis-promoting kinase","volume":"274","author":"Reszka","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1172\/JCI116422","article-title":"Bisphosphonates act on rat bone resorption through the mediation of osteoblasts","volume":"91","author":"Sahni","year":"1993","journal-title":"J. Clin. Investig."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bone.2010.10.159","article-title":"Bisphosphonate effects on bone turnover, microdamage, and mechanical properties: What we think we know and what we know that we don\u2019t know","volume":"49","author":"Allen","year":"2011","journal-title":"Bone"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.bone.2010.08.008","article-title":"Novel actions of bisphosphonates in bone: Preservation of osteoblast and osteocyte viability","volume":"49","author":"Bellido","year":"2011","journal-title":"Bone"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1359\/jbmr.080617","article-title":"Connexin 43 is required for the anti-apoptotic effect of bisphosphonates on osteocytes and osteoblasts in vivo","volume":"23","author":"Plotkin","year":"2008","journal-title":"J. Bone Miner. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.bone.2013.09.023","article-title":"Update on long-term treatment with bisphosphonates for postmenopausal osteoporosis: A systematic review","volume":"58","author":"Eriksen","year":"2014","journal-title":"Bone"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa030897","article-title":"Ten years\u2019 experience with alendronate for osteoporosis in postmenopausal women","volume":"350","author":"Bone","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1359\/jbmr.070906","article-title":"Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure","volume":"23","author":"Recker","year":"2008","journal-title":"J. Bone Miner. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1056\/NEJMp1202619","article-title":"Bisphosphonates for Osteoporosis\u2014Where do we go from here?","volume":"366","author":"Whitaker","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1590\/S0004-27302006000400018","article-title":"Bisphosphonates","volume":"50","author":"McClung","year":"2006","journal-title":"Arq. Bras. Endocrinol. Metabol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.bone.2009.05.008","article-title":"Histologic and histomorphometric features of bisphosphonate-related osteonecrosis of the jaws: An analysis of 31 cases with confocal laser scanning microscopy","volume":"45","author":"Favia","year":"2009","journal-title":"Bone"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00198-010-1453-5","article-title":"Subtrochanteric fractures after long-term treatment with bisphosphonates: A European society on clinical and economic aspects of osteoporosis and osteoarthritis, and international osteoporosis foundation working group report","volume":"22","author":"Rizzoli","year":"2011","journal-title":"Osteoporos. Int."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"h3783","DOI":"10.1136\/bmj.h3783","article-title":"Bisphosphonates for the prevention and treatment of osteoporosis","volume":"351","author":"Maraka","year":"2015","journal-title":"BMJ"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.bone.2011.01.003","article-title":"Safety of bisphosphonates","volume":"49","author":"Pazianas","year":"2011","journal-title":"Bone"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.bone.2013.08.007","article-title":"Jaw bone marrow-derived osteoclast precursors internalize more bisphosphonate than long-bone marrow precursors","volume":"57","author":"Vermeer","year":"2013","journal-title":"Bone"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1200\/JCO.2005.04.2465","article-title":"Osteonecrosis of the jaw in multiple myeloma patients: Clinical features and risk factors","volume":"24","author":"Badros","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/jbmr.288","article-title":"Oral bisphosphonates and risk of subtrochanteric or diaphyseal femur fractures in a population-based cohort","volume":"26","author":"Kim","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"6210","DOI":"10.1021\/acs.nanolett.7b02888","article-title":"Micrometer-sized magnesium whitlockite crystals in micropetrosis of bisphosphonate-exposed human alveolar bone","volume":"17","author":"Shah","year":"2017","journal-title":"Nano Lett."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1002\/adma.200602497","article-title":"Composite nanocrystals provide new insight on alendronate interaction with hydroxyapatite structure","volume":"19","author":"Boanini","year":"2007","journal-title":"Adv. Mater."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"15812","DOI":"10.1021\/jp304472s","article-title":"Time course of zoledronate interaction with hydroxyapatite nanocrystals","volume":"116","author":"Boanini","year":"2012","journal-title":"J. Phys. Chem. C"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s10973-016-5905-9","article-title":"Hydroxyapatite\u2013alendronate composite systems for biocompatibile materials","volume":"127","author":"Neamtu","year":"2017","journal-title":"J. Therm. Anal. Calorim."},{"key":"ref_47","unstructured":"Salamanna, F., Giavaresi, G., Parrilli, A., Torricelli, P., Boanini, E., Bigi, A., and Fini, M. (2017). Antiresorptive properties of strontium substituted and alendronate functionalized hydroxyapatite nanocrystals in an ovariectomized rat spinal arthrodesis model. Mater. Sci. Eng. C, in press."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.biomaterials.2011.09.092","article-title":"The effect of zoledronate-hydroxyapatite nanocomposites on osteoclasts and osteoblast-like cells in vitro","volume":"33","author":"Boanini","year":"2012","journal-title":"Biomaterials"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"5619","DOI":"10.1016\/j.biomaterials.2014.03.053","article-title":"Combined effect of strontium and zoledronate on hydroxyapatite structure and bone cell responses","volume":"35","author":"Boanini","year":"2014","journal-title":"Biomaterials"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1007\/s00198-004-1753-8","article-title":"Strontium ranelate: A novel mode of action optimizing bone formation and resorption","volume":"16","author":"Marie","year":"2005","journal-title":"Osteoporos. Int."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1002\/jbm.a.36192","article-title":"Quercetin and alendronate multi-functionalized materials as tools to hinder oxidative stress damage","volume":"105","author":"Forte","year":"2017","journal-title":"J. Biomed. Mater. Res. Part A"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.actbio.2017.02.040","article-title":"Antiresorptive and anti-angiogenetic octacalcium phosphate functionalized with bisphosphonates: An in vitro tri-culture study","volume":"54","author":"Forte","year":"2017","journal-title":"Acta Biomater."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.bone.2005.05.003","article-title":"Novel insights into actions of bisphosphonates on bone: Differences in interactions with hydroxyapatite","volume":"38","author":"Nancollas","year":"2006","journal-title":"Bone"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/j.biomaterials.2004.05.019","article-title":"Novel biomaterials for bisphosphonate delivery","volume":"26","author":"Josse","year":"2005","journal-title":"Biomaterials"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1021\/cm702584d","article-title":"Reaction of zoledronate with \u03b2-tricalcium phosphate for the design of potential drug device combined systems","volume":"20","author":"Fayon","year":"2008","journal-title":"Chem. Mater."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/adma.200306340","article-title":"Chemically modified calcium phosphates as novel materials for bisphosphonate delivery","volume":"16","author":"Josse","year":"2004","journal-title":"Adv. Mater."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1021\/ja0759949","article-title":"NMR investigations of the static and dynamic structures of bisphosphonates on human bone: A molecular model","volume":"130","author":"Mukherjee","year":"2008","journal-title":"J. Am. Chem. Soc."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1039\/b503680a","article-title":"Hybrid materials applied to biotechnologies: Coating of calcium phosphates for the design of implants active against bone resorption disorders","volume":"15","author":"Montavon","year":"2005","journal-title":"J. Mater. Chem."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/jbm.a.31989","article-title":"Controlled release of bisphosphonate from a calcium phosphate biomaterial inhibits osteoclastic resorption in vitro","volume":"89","author":"Faucheux","year":"2009","journal-title":"J. Biomed. Mater. Res. Part A"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1021\/ml5004603","article-title":"Structural requirements for bisphosphonate binding on hydroxyapatite: NMR study of bisphosphonate partial esters","volume":"6","author":"Puljula","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1021\/la3046548","article-title":"Interaction between a bisphosphonate, tiludronate, and biomimetic nanocrystalline apatites","volume":"29","author":"Pascaud","year":"2013","journal-title":"Langmuir"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jcis.2014.01.017","article-title":"Infrared, Raman and NMR investigations of risedronate adsorption on nanocrystalline apatites","volume":"420","author":"Errassifi","year":"2014","journal-title":"J. Colloid Interface Sci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1007\/s10856-014-5218-0","article-title":"Adsorption on apatitic calcium phosphates for drug delivery: Interaction with bisphosphonate molecules","volume":"25","author":"Pascaud","year":"2014","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.colsurfb.2017.09.055","article-title":"Hydroxyapatite functionalization to trigger adsorption and release of risedronate","volume":"160","author":"Forte","year":"2017","journal-title":"Colloid Surf. B Biointerfaces"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.msec.2016.10.066","article-title":"Novel therapeutic intervention for osteoporosis prepared with strontium hydroxyapatite and zoledronic acid: In vitro and pharmacodynamic evaluation","volume":"71","author":"Khajuria","year":"2017","journal-title":"Mater. Sci. Eng. C"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1016\/j.actbio.2010.01.036","article-title":"New processing approaches in calcium phosphate cements and their applications in regenerative medicine","volume":"6","author":"Ginebra","year":"2010","journal-title":"Acta Biomater."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.actbio.2013.11.001","article-title":"Calcium phosphate cements for bone substitution: Chemistry, handling and mechanical properties","volume":"10","author":"Zhang","year":"2014","journal-title":"Acta Biomater."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4012\/dmj.28.1","article-title":"Next generation calcium phosphate-based biomaterials","volume":"28","author":"Chow","year":"2009","journal-title":"Dent. Mater. J."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.actbio.2011.11.021","article-title":"Silicon-stabilized \u03b1-tricalcium phosphate and its use in a calcium phosphate cement: Characterization and cell response","volume":"8","author":"Mestres","year":"2012","journal-title":"Acta Biomater."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3390\/jfb4040209","article-title":"Self-setting calcium orthophosphate formulations","volume":"4","author":"Dorozhkin","year":"2013","journal-title":"J. Funct. Biomater."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1039\/C2TB00061J","article-title":"Calcium phosphate-based cements: Clinical needs and recent progress","volume":"1","author":"Sugawara","year":"2013","journal-title":"J. Mater. Chem. B"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1039\/b706411j","article-title":"Reactivity of calcium phosphate cements","volume":"17","author":"Bohner","year":"2007","journal-title":"J. Mater. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.1021\/cm049363e","article-title":"Setting mechanism of a biomimetic bone cement","volume":"16","author":"Bigi","year":"2004","journal-title":"Chem. Mater."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/jbm.b.30830","article-title":"Advantages of using glycolic acid as a retardant in a brushite forming cement","volume":"83","author":"Marino","year":"2007","journal-title":"J. Biomed. Mater. Res. Part A"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.actbio.2008.08.005","article-title":"High-strength resorbable brushite bone cement with controlled drug-releasing capabilities","volume":"5","author":"Hofmann","year":"2009","journal-title":"Acta Biomater."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.jinorgbio.2011.05.006","article-title":"Optimization of a biomimetic bone cement: Role of DCPD","volume":"105","author":"Panzavolta","year":"2011","journal-title":"J. Inorg. Biochem."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.actbio.2011.08.005","article-title":"Dicalcium phosphate cements: Brushite and monetite","volume":"8","author":"Tamimi","year":"2012","journal-title":"Acta Biomater."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.actbio.2014.09.006","article-title":"Local drug delivery for enhancing fracture healing in osteoporotic bone","volume":"11","author":"Alini","year":"2015","journal-title":"Acta Biomater."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.addr.2012.01.008","article-title":"Calcium phosphate cements as drug delivery materials","volume":"64","author":"Ginebra","year":"2012","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jinorgbio.2008.09.012","article-title":"Alendronate and pamidronate calcium phosphate bone cements: Setting properties and in vitro response of osteoblast and osteoclast cells","volume":"103","author":"Panzavolta","year":"2009","journal-title":"J. Inorg. Biochem."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.actbio.2010.09.017","article-title":"Investigation of alendronate-doped apatitic cements as a potential technology for the prevention of osteoporotic hip fractures: Critical influence of the drug introduction mode on the in vitro cement properties","volume":"7","author":"Schnitzler","year":"2011","journal-title":"Acta Biomater."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3928\/01477447-20100625-15","article-title":"Evaluation of a novel osteoporotic drug delivery system in vitro: Alendronate-loaded calcium phosphate cement","volume":"33","author":"Jindong","year":"2010","journal-title":"Orthopedics"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1098\/rsta.2010.0006","article-title":"Molecular mechanisms of crystallization impacting calcium phosphate cements","volume":"368","author":"Giocondi","year":"2010","journal-title":"Philos. Trans. R. Soc. A"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.msec.2014.05.043","article-title":"Microstructure and properties of alendronate-loaded calcium phosphate cement","volume":"42","author":"Shen","year":"2014","journal-title":"Mater. Sci. Eng. C"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jinorgbio.2010.06.008","article-title":"Functionalization of biomimetic calcium phosphate bone cements with alendronate","volume":"104","author":"Panzavolta","year":"2010","journal-title":"J. Inorg. Biochem."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"7776","DOI":"10.1016\/j.biomaterials.2010.06.047","article-title":"In vivo bone augmentation in an osteoporotic environment using bisphosphonate-loaded calcium deficient apatite","volume":"31","author":"Verron","year":"2010","journal-title":"Biomaterials"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejpb.2017.10.002","article-title":"Spray-congealed solid lipid microparticles as a new tool for the controlled release of bisphosphonates from a calcium phosphate bone cement","volume":"122","author":"Dolci","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/jbm.a.30792","article-title":"Adsorption of bisphosphonate onto hydroxyapatite using a novel co-precipitation technique for bone growth enhancement","volume":"79","author":"McLeod","year":"2006","journal-title":"J. Biomed. Mater. Res. Part A"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"478","DOI":"10.11607\/jomi.3423","article-title":"Bone formation on biomimetic calcium phosphate-coated and zoledronate-immobilized titanium implants in osteoporotic rat tibiae","volume":"29","author":"Pyo","year":"2014","journal-title":"Int. J. Oral Maxillofac. Implants"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1039\/C5TB01956G","article-title":"Alendronate-loaded hydroxyapatite-TiO2 nanotubes for improved bone formation in osteoporotic rabbits","volume":"4","author":"Shen","year":"2016","journal-title":"J. Mater. Chem. B"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10856-011-4524-z","article-title":"Biomimetic coating of bisphosphonate incorporated CDHA on Ti6Al4V","volume":"23","author":"Zhou","year":"2012","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1016\/j.apsusc.2006.05.031","article-title":"XPS and bioactivity study of the bisphosphonate pamidronate adsorbed onto plasma sprayed hydroxyapatite coatings","volume":"253","author":"McLeod","year":"2006","journal-title":"Appl. Surf. Sci."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1016\/j.jss.2012.02.003","article-title":"The inhibitory effect of alendronate-hydroxyapatite composite coating on wear debris-induced peri-implant high bone turnover","volume":"179","author":"Niu","year":"2013","journal-title":"J. Surg. Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.biomaterials.2008.12.025","article-title":"The effect of surface immobilized bisphosphonates on the fixation of hydroxyapatite-coated titanium implants in ovariectomized rats","volume":"30","author":"Gao","year":"2009","journal-title":"Biomaterials"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.apsusc.2014.12.072","article-title":"Hydroxyapatite nanocrystals functionalized with alendronate as bioactive components for bone implant coatings to decrease osteoclastic activity","volume":"328","author":"Bosco","year":"2015","journal-title":"Appl. Surf. Sci."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"6168","DOI":"10.1016\/j.biomaterials.2009.07.066","article-title":"Biofunctional alendronate-hydroxyapatite thin films deposited by Matrix Assisted Pulsed Laser Evaporation","volume":"30","author":"Bigi","year":"2009","journal-title":"Biomaterials"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcis.2015.01.088","article-title":"Strontium and zoledronate hydroxyapatites graded composite coatings for bone prostheses","volume":"448","author":"Boanini","year":"2015","journal-title":"J. Colloid Interface Sci."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.addr.2007.08.041","article-title":"Biomimetic materials for tissue engineering","volume":"60","author":"Ma","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/adhm.201300562","article-title":"Biopolymer\/calcium phosphate scaffolds for bone tissue engineering","volume":"3","author":"Li","year":"2014","journal-title":"Adv. Healthc. Mater."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.tibtech.2012.07.005","article-title":"Recent advances in bone tissue engineering scaffolds","volume":"30","author":"Bose","year":"2012","journal-title":"Trends Biotechnol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1016\/j.actbio.2011.07.002","article-title":"Various preparation methods of highly porous hydroxyapatite\/polymer nanoscale biocomposites for bone regeneration","volume":"7","author":"Sun","year":"2011","journal-title":"Acta Biomater."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.actbio.2010.09.039","article-title":"Structural and material approaches to bone tissue engineering in powder-based three-dimensional printing","volume":"7","author":"Butscher","year":"2011","journal-title":"Acta Biomater."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/term.310","article-title":"Optimized electro- and wet-spinning techniques for the production of polymeric fibrous scaffolds loaded with bisphosphonate and hydroxyapatite","volume":"5","author":"Puppi","year":"2011","journal-title":"J. Tissue Eng. Regener. Med."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"26738","DOI":"10.3390\/ijms161125982","article-title":"The effect of alendronate loaded biphasic calcium phosphate scaffolds on bone regeneration in a rat tibial defect model","volume":"16","author":"Park","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1016\/j.actbio.2014.01.016","article-title":"A collagen\u2013hydroxyapatite scaffold allows for binding and co-delivery of recombinant bone morphogenetic proteins and bisphosphonates","volume":"10","author":"Murphy","year":"2014","journal-title":"Acta Biomater."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ijpharm.2015.03.048","article-title":"Tuning dual-drug release from composite scaffolds for bone regeneration","volume":"486","author":"Paris","year":"2015","journal-title":"Int. J. Pharm."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"9955","DOI":"10.1021\/am501048n","article-title":"Polycaprolactone-coated 3D printed tricalcium phosphate scaffolds for bone tissue engineering: In vitro alendronate release behavior and local delivery effect on in vivo osteogenesis","volume":"6","author":"Tarafder","year":"2014","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"98","DOI":"10.22203\/eCM.v027a08","article-title":"Spatial control of bone formation using a porous polymer scaffold co-delivering anabolic rhBMP-2 and anti-resorptive agents","volume":"27","author":"Yu","year":"2014","journal-title":"Eur. Cell Mater."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1600272","DOI":"10.1002\/mabi.201600272","article-title":"Gelatin porous scaffolds as delivery systems of calcium alendronate","volume":"17","author":"Panzavolta","year":"2017","journal-title":"Macromol. Biosci."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/term.2066","article-title":"Development and dissolution studies of bisphosphonate (clodronate)-containing hydroxyapatite\u2013polylactic acid biocomposites for slow drug delivery","volume":"11","author":"Macha","year":"2017","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1021\/mp200028w","article-title":"Bisphosphonate-derivatized liposomes to control drug release from collagen\/hydroxyapatite scaffolds","volume":"8","author":"Wang","year":"2011","journal-title":"Mol. Pharm."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"6816","DOI":"10.1021\/acsami.6b14782","article-title":"Nano-hydroxyapatite bone substitute functionalized with bone active molecules for enhanced cranial bone regeneration","volume":"9","author":"Teotia","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jconrel.2010.06.016","article-title":"In situ fabrication of alendronate loaded calcium phosphate microspheres: Controlled release for inhibition of osteoclastogenesis","volume":"147","author":"Kim","year":"2010","journal-title":"J. Control. Release"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.matlet.2013.04.082","article-title":"Micro-structured hydroxyapatite microspheres for local delivery of alendronate and BMP-2 carriers","volume":"105","author":"Lee","year":"2013","journal-title":"Mater. Lett."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s11095-008-9759-0","article-title":"Enhancing alendronate release from a novel PLGA\/hydroxyapatite microspheric system for bone repairing applications","volume":"26","author":"Shi","year":"2009","journal-title":"Pharm. Res."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1007\/s10856-014-5289-y","article-title":"Emulsion cross-linked chitosan\/nanohydroxyapatite microspheres for controlled release of alendronate","volume":"25","author":"Wu","year":"2014","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jcis.2011.06.061","article-title":"Biomimetic gelatin\u2013octacalcium phosphate core\u2013shell microspheres","volume":"362","author":"Boanini","year":"2011","journal-title":"J. Colloid Interface Sci."}],"container-title":["Journal of Functional Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-4983\/9\/1\/6\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T14:51:08Z","timestamp":1760194268000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-4983\/9\/1\/6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,13]]},"references-count":117,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,3]]}},"alternative-id":["jfb9010006"],"URL":"https:\/\/doi.org\/10.3390\/jfb9010006","relation":{},"ISSN":["2079-4983"],"issn-type":[{"value":"2079-4983","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,13]]}}}